Filtros de búsqueda

Lista de obras de V Roldan

A Nurse-led Atrial Fibrillation Clinic: Impact on Anticoagulation Therapy and Clinical Outcomes

artículo científico publicado en 2020

A Propensity Score Matched Comparison of Clinical Outcomes in Atrial Fibrillation Patients Taking Vitamin K Antagonists: Comparing the "Real-World" vs Clinical Trials

scientific article published on 02 May 2018

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

artículo científico publicado en 2002

A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels

scientific article published on 07 November 2007

A new method to quantify β-antithrombin glycoform in plasma reveals increased levels during the acute stroke event

artículo científico publicado en 2015

A nonsense polymorphism in the protein Z-dependent protease inhibitor increases the risk for venous thrombosis

artículo científico publicado en 2006

A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction.

artículo científico publicado en 2005

ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant

artículo científico publicado en 2020

An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization

artículo científico publicado en 2010

Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation

artículo científico publicado en 2012

Annexin V levels in survivors of early myocardial infarction

artículo científico publicado en 2002

Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation

scientific article published on 01 July 2000

Antiplatelet therapy combined with acenocoumarol in relation to major bleeding, ischaemic stroke and mortality

artículo científico publicado en 2018

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

artículo científico publicado en 2007

Antithrombotic management in patients undergoing electrophysiological procedures: a European Heart Rhythm Association (EHRA) position document endorsed by the ESC Working Group Thrombosis, Heart Rhythm Society (HRS), and Asia Pacific Heart Rhythm Soc

article

Applicability of the modified CHA2DS2-VASc score for stroke risk stratification in Caucasian atrial fibrillation patients

artículo científico publicado en 2016

Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain

artículo científico publicado en 2005

Are we content with lowering blood pressure alone, or should we be asking something more from the antihypertensive drugs we use?: effects of antihypertensive agents on fibrinolytic function.

artículo científico publicado en 2004

Assessing Bleeding Risk in Atrial Fibrillation Patients: Comparing a Bleeding Risk Score Based Only on Modifiable Bleeding Risk Factors against the HAS-BLED Score. The AMADEUS Trial

artículo científico publicado en 2017

Assessment of bleeding risk in acute ill medical patients. An essential part of venous thromboembolism prevention

artículo científico publicado en 2016

Assessment of two contact activation reagents for the diagnosis of congenital factor XI deficiency.

artículo científico publicado en 2018

Association of the thrombomodulin gene c.1418C>T polymorphism with thrombomodulin levels and with venous thrombosis risk

artículo científico publicado en 2013

Atherosclerosis and thromboembolic risk in atrial fibrillation: focus on peripheral vascular disease.

artículo científico publicado en 2012

Biomarkers in atrial fibrillation: an overview

artículo científico

Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis

artículo científico publicado en 2009

Biomarkers: GDF-15 and risk stratification in atrial fibrillation

artículo científico publicado en 2014

Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.

artículo científico publicado en 2009

CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis.

artículo científico publicado en 2010

Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation

artículo científico publicado en 2013

Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients

artículo científico publicado en 2017

Common carotid artery intima-media thickness and intracranial pulsatility index in non-ST-elevation acute coronary syndromes

artículo científico publicado en 2007

Comparative determination and monitoring of biomarkers of necrosis and myocardial remodeling between radiofrequency ablation and cryoablation

artículo científico publicado en 2012

Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial

artículo científico publicado en 2017

Comparison of estimated glomerular filtration rate equations for dosing new oral anticoagulants in patients with atrial fibrillation

artículo científico publicado en 2014

Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients

scientific article published on 16 March 2018

Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody

artículo científico publicado en 2008

Conventional and new oral anticoagulants in the treatment of chest disease and its complications

scientific article published on 01 August 2013

Correlation of plasma von Willebrand factor levels, an index of endothelial damage/dysfunction, with two point-based stroke risk stratification scores in atrial fibrillation

artículo científico publicado en 2005

Creating a genotype-based dosing algorithm for acenocoumarol steady dose.

artículo científico publicado en 2012

Dabigatran for the prevention of stroke in atrial fibrillation: is RE-LY reliable?

artículo científico publicado en 2012

Deep venous thrombosis or pulmonary embolism and factor V Leiden: enigma or paradox.

artículo científico publicado en 2010

Development of the human submandibular salivary gland

artículo científico publicado en 1993

Diurnal variation in the intensity of anticoagulation in atrial fibrillation.

artículo científico publicado en 2002

Diurnal variation of international normalised ratio in patients under oral anticoagulation.

artículo científico publicado en 2002

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

artículo científico publicado en 2002

Does chronic kidney disease improve the predictive value of the CHADS2 and CHA2DS2-VASc stroke stratification risk scores for atrial fibrillation?

artículo científico publicado en 2013

Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

artículo científico publicado en 2006

Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?

artículo científico publicado en 2017

Edoxaban in Japanese patients with nonvalvular atrial fibrillation: not the same dose for everybody

artículo científico publicado en 2012

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals

artículo científico publicado en 2019

Effect of VKORC1, CYP2C9 and CYP4F2 genetic variants in early outcomes during acenocoumarol treatment.

artículo científico publicado en 2014

Effect of factor XIII VAL34LEU polymorphism on thrombolytic therapy in premature myocardial infarction

scientific article published on 01 August 2002

Effect of maximum dose of atorvastatin on inflammation, thrombogenesis and fibrinolysis in high-risk patients with ischemic heart disease

artículo científico publicado en 2005

Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion

artículo científico publicado en 2006

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

artículo científico publicado en 2014

Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease

artículo científico publicado en 2008

Efficacy and Safety of Peri-procedural Bridging Therapy with Low Molecular Weight Heparin in Atrial Fibrillation Patients under Vitamin K Antagonists

artículo científico publicado en 2019

Efficacy and safety of drug-eluting stent use in patients with atrial fibrillation

artículo científico publicado en 2009

Endothelial protein C receptor polymorphisms and risk of myocardial infarction

artículo científico publicado en 2008

Enhancing the 'real world' prediction of cardiovascular events and major bleeding with the CHA2DS2-VASc and HAS-BLED scores using multiple biomarkers.

artículo científico publicado en 2017

Estimated Effectiveness and Safety of Nonvitamin K Antagonist Oral Anticoagulants Compared With Optimally Acenocoumarol Anticoagulated "Real-World" in Patients With Atrial Fibrillation

scientific article published on 02 June 2018

Estimated absolute effects on efficacy and safety outcomes of using non-vitamin K antagonist oral anticoagulants in 'real-world' atrial fibrillation patients: A comparison with optimally acenocoumarol anticoagulated patients

artículo científico publicado en 2017

Evaluation of HAS-BLED and ORBIT Bleeding Risk Scores in Nonvalvular Atrial Fibrillation Patients Receiving Oral Anticoagulants

artículo científico publicado en 2016

Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk

artículo científico publicado en 2008

Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation.

artículo científico publicado en 2004

Factors Affecting the Quality of Anticoagulation With Vitamin K Antagonists in Venous Thromboembolism Patients.

artículo científico publicado en 2016

Fibrinolytic function and atrial fibrillation

artículo científico publicado en 2003

Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction

scientific article published on 01 March 2005

Fluctuations in coagulation activity among patients with atrial fibrillation who are stably anticoagulated.

artículo científico publicado en 2006

Gamma-glutamyl carboxylase R325Q polymorphism on the response of acenocoumarol.

artículo científico publicado en 2008

Genetic polymorphisms and atrial fibrillation: Insights into the prothrombotic state and thromboembolic risk

artículo científico publicado en 2010

Genetic polymorphisms and thromoembolic risk in atrial fibrillation

artículo científico publicado en 2004

Genotype-guided therapy improves initial acenocoumarol dosing. Results from a prospective randomised study.

artículo científico publicado en 2015

High incidence of FXI deficiency in a Spanish town caused by 11 different mutations and the first duplication of F11: Results from the Yecla study

artículo científico publicado en 2017

Hsp70 protects from stroke in atrial fibrillation patients by preventing thrombosis without increased bleeding risk

artículo científico publicado en 2016

Hypofibrinolysis in atrial fibrillation

scientific article published on 01 December 1998

Hypoglycosylation is a common finding in antithrombin deficiency in the absence of a SERPINC1 gene defect

artículo científico publicado en 2016

Hypouricemic effect of statins: another pleiotropic benefit?

artículo científico publicado en 2010

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

artículo científico publicado en 2019

Impact of Variations in Kidney Function on Nonvitamin K Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Recent Acute Heart Failure

artículo científico publicado en 2015

Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients

artículo científico publicado en 2015

Implications of pharmacogenetics for oral anticoagulants metabolism.

artículo científico publicado en 2009

Importance of time in therapeutic range on bleeding risk prediction using clinical risk scores in patients with atrial fibrillation

artículo científico publicado en 2017

Increasing therapy-related myeloid neoplasms in multiple myeloma

scientific article published on 07 December 2018

Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study

artículo científico publicado en 2011

Influence of electrical cardioversion on inflammation and indexes of structural remodeling, in persistent atrial fibrillation

scientific article published on 30 January 2008

Influence of smoking habit on cardiac functional capacity and diastolic function in healthy people

artículo científico publicado en 2005

Influence of the F12 -4 C>T polymorphism on hemostatic tests

artículo científico publicado en 2010

Influence of the matrix type over the concentration of GDF-15

scientific article published on 08 September 2020

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

artículo científico publicado en 2003

Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality

artículo científico publicado en 2018

Is an advanced age an additive risk factor to the prothrombotic or hypercoagulable state in atrial fibrillation?

artículo científico publicado en 2005

Is plasminogen activator inhibitor-1 (PAI-1) a surrogate marker of vascular damage?

artículo científico publicado en 2011

Is the ORBIT Bleeding Risk Score Superior to the HAS-BLED Score in Anticoagulated Atrial Fibrillation Patients?

artículo científico publicado en 2016

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

artículo científico publicado en 2003

JAK2 V617F, hemostatic polymorphisms, and clinical features as risk factors for arterial thrombotic events in essential thrombocythemia

artículo científico publicado en 2008

Kinetics and mechanism of the reduction of CrVI and CrV by D-lactobionic acid.

artículo científico publicado en 2004

Left atrial remodelling in hypertrophic cardiomyopathy: relation with exercise capacity and biochemical markers of tissue strain and remodelling.

artículo científico publicado en 2009

Letter by Roldán et al regarding article, "Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass"

artículo científico publicado en 2008

Levels of tissue factor pathway inhibitor in lupus patients correlate with lupus activity and endothelial damage markers.

artículo científico publicado en 2002

Long-Term Predictors of Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Undergoing Electrical Cardioversion.

artículo científico publicado en 2016

Long-Term Stroke Risk Prediction in Patients With Atrial Fibrillation: Comparison of the ABC-Stroke and CHA2DS2-VASc Scores

artículo científico publicado en 2017

Long-term bleeding risk prediction in 'real world' patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores. The Murcia Atrial Fibrillation Project.

artículo científico publicado en 2017

Matrix metalloproteinases in atrial fibrillation

artículo científico publicado en 2004

Measuring the prognostic impact of ferritin levels in myelodysplastic syndrome patients: the role of susceptibility biases.

artículo científico publicado en 2009

MiR-146a Regulates Neutrophil Extracellular Trap Formation That Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

artículo científico publicado en 2018

MiRNA-Based Regulation of Hemostatic Factors through Hepatic Nuclear Factor-4 Alpha.

artículo científico publicado en 2016

Murcia atrial fibrillation project II: protocol for a prospective observational study in patients with atrial fibrillation

artículo científico publicado en 2019

Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation

artículo científico publicado en 2017

Novel oral anticoagulants in cardiovascular disease

artículo científico publicado en 2013

Optimizing Vitamin K Antagonist Treatment in Patients with Mechanical Heart Valve Prosthesis

artículo científico publicado en 2018

Oral anticoagulation and comorbidities; too many details for clinical practice?

artículo científico publicado en 2018

Oral anticoagulation improves the prognosis of octogenarian patients with atrial fibrillation undergoing percutaneous coronary intervention and stenting

artículo científico publicado en 2012

Oral anticoagulation in chronic kidney disease: A huge challenge

scientific article published on 25 May 2012

Particulate Matter and Temperature: Increased Risk of Adverse Clinical Outcomes in Patients With Atrial Fibrillation

artículo científico publicado en 2020

Peri-operative management of ophthalmic patients taking antithrombotic therapy

artículo científico publicado en 2011

Pharmacogenetics in cardiovascular antithrombotic therapy

artículo científico publicado en 2005

Pharmacogenetics in cardiovascular antithrombotic therapy

artículo científico publicado en 2009

Pharmacogenetics of acenocoumarol in patients with extreme dose requirements.

artículo científico publicado en 2010

Pharmacogenetics of vitamin K antagonists and bleeding risk prediction in atrial fibrillation.

artículo científico publicado en 2018

Pilot Study on the Role of Circulating miRNAs for the Improvement of the Predictive Ability of the 2MACE Score in Patients with Atrial Fibrillation

scientific article published on 12 November 2020

Plasma angiogenin levels in acute coronary syndromes: implications for prognosis

artículo científico publicado en 2007

Plasma von Willebrand factor levels are an independent risk factor for adverse events including mortality and major bleeding in anticoagulated atrial fibrillation patients.

artículo científico publicado en 2011

Pneumonia caused by Salmonella in a patient with myeloma

artículo científico publicado en 1995

Practical issues with the use of rivaroxaban

artículo científico publicado en 2013

Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

artículo científico publicado en 2020

Predicting bleeding risk after coronary surgery: Let's focus on modifiable risk factors and simple, practical decision making

artículo científico publicado en 2017

Prediction of long-term net clinical outcomes using the TIMI-AF score: Comparison with CHA2DS2-VASc and HAS-BLED.

artículo científico publicado en 2017

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

artículo científico publicado en 2012

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

artículo científico publicado en 2013

Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers

artículo científico publicado en 2008

Premature myocardial infarction: clinical profile and angiographic findings

scientific article published on 25 April 2007

Pro: "Antidote for new anticoagulants"--specific target of inhibition requires a specific target for neutralisation

artículo científico publicado en 2012

Prognostic role of MIR146A polymorphisms for cardiovascular events in atrial fibrillation.

artículo científico publicado en 2014

Prognostic value of annexin A5 -1 C/T polymorphism in a long term follow-up after premature myocardial infarction

artículo científico publicado en 2007

Prognostic value of mean platelet volume in patients with non-ST-elevation acute coronary syndrome

artículo científico publicado en 2011

Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples

scientific article published on 01 June 2002

Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation

scientific article published on 01 October 1999

Quality of oral anticoagulation with vitamin K antagonists in 'real-world' patients with atrial fibrillation: a report from the prospective multicentre FANTASIIA registry.

artículo científico publicado en 2017

Reduced Time in Therapeutic Range and Higher Mortality in Atrial Fibrillation Patients Taking Acenocoumarol.

artículo científico publicado en 2017

Refining Stroke and Bleeding Prediction in Atrial Fibrillation by Adding Consecutive Biomarkers to Clinical Risk Scores

artículo científico publicado en 2019

Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens.

artículo científico publicado en 2017

Relation of Renal Dysfunction to Quality of Anticoagulation Control in Patients with Atrial Fibrillation: The FANTASIIA Registry.

artículo científico publicado en 2018

Relation of interleukin-6 levels and prothrombin fragment 1+2 to a point-based score for stroke risk in atrial fibrillation

artículo científico publicado en 2005

Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.

artículo científico publicado en 2012

Renal impairment in a "real-life" cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding).

artículo científico publicado en 2013

Role of factor XIII Val34Leu polymorphism in patients <45 years of age with acute myocardial infarction.

artículo científico publicado en 2003

SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation.

artículo científico publicado en 2014

Short-term effect of miglustat in every day clinical use in treatment-naïve or previously treated patients with type 1 Gaucher's disease.

artículo científico publicado en 2006

Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?

artículo científico publicado en 2012

Soluble E-selectin in cardiovascular disease and its risk factors. A review of the literature

artículo científico publicado en 2003

Soluble E-selectin, interleukin-6 and tissue factor in two cases of meningococcal septicaemia.

artículo científico publicado en 2004

Soluble Fibrin Monomer Complex and Prediction of Cardiovascular Events in Atrial Fibrillation: The Observational Murcia Atrial Fibrillation Project.

artículo científico publicado en 2018

Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting

scientific article published on 07 November 2005

Strategies for prediction and early detection of atrial fibrillation: present and future.

artículo científico publicado en 2017

Study of 18 functional hemostatic polymorphisms in mucocutaneous bleeding disorders

artículo científico publicado en 2010

Subclinical atherosclerotic endothelial damage as predictor for bleeding in anticoagulated atrial fibrillation patients

artículo científico publicado en 2012

Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

artículo científico publicado en 2010

Synergistic association between hypercholesterolemia and the C46T factor XII polymorphism for developing premature myocardial infarction

artículo científico publicado en 2005

The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.

artículo científico publicado en 2013

The HAS-BLED score predicts long-term major bleeding and death in anticoagulated non-valvular atrial fibrillation patients undergoing electrical cardioversion.

artículo científico publicado en 2016

The SAMe-TT2R2 Score Predicts Poor Anticoagulation Control in AF Patients: A Prospective 'Real-world' Inception Cohort Study.

artículo científico publicado en 2015

The SAMe-TT2R2 score and decision-making between a vitamin K antagonist or a non-vitamin K antagonist oral anticoagulant in patients with atrial fibrillation.

artículo científico publicado en 2015

The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

artículo científico publicado en 2019

The additive value of biomarkers to clinical risk scores in acute coronary syndrome. Are biomarkers really ready for real world usage?

scientific article published on 01 February 2010

The importance of excellence in the quality of anticoagulation control whilst taking vitamin K antagonists

artículo científico publicado en 2015

The pharmacogenetics of antiplatelet drugs.

artículo científico publicado en 2007

The prognostic role of the adiponectin levels in atrial fibrillation

artículo científico publicado en 2012

The prognostic value of biomarkers after a premature myocardial infarction

artículo científico publicado en 2009

The role of tissue plasminogen activator on the progression of the coronary disease

artículo científico publicado en 2002

Treatment strategies for patients with atrial fibrillation and anticoagulant-associated intracranial hemorrhage: an overview of the pharmacotherapy

artículo científico publicado en 2020

Usefulness of N-terminal pro-B-type natriuretic Peptide levels for stroke risk prediction in anticoagulated patients with atrial fibrillation.

artículo científico publicado en 2014

Usefulness of the 2MACE Score to Predicts Adverse Cardiovascular Events in Patients With Atrial Fibrillation.

artículo científico publicado en 2017

Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications

scientific article published on 27 May 2008

Von Willebrand factor is associated with atrial fibrillation development in ischaemic patients after cardiac surgery

scientific article published on 12 November 2015

[Angiogenesis and statins, the highest the dose the best? ]

scientific article published on 01 June 2003

[Can we expect polymorphisms to answer our questions?]

scientific article published on 01 November 2004

[Clinical perspectives on the management of bleeding in patients on oral anticoagulants: the DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsal)]

[Factor XIII Val34Leu polymorphism and premature myocardial infarction]

artículo científico publicado en 2002

[Hemolytic anemia secondary to paravalvular regurgitation]

artículo científico publicado en 2002

[Serum erythropoietin levels in newborn infants at term]

scientific article published on 01 June 1997

[Severe hypercalcaemia as initial manifestation of B-cell non-Hodgkin's lymphoma]

artículo científico publicado en 2001

[Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence]

artículo científico publicado en 2012

miR-146a deficiency in hematopoietic cells is not involved in the development of atherosclerosis.

artículo científico publicado en 2018

sST2 levels are associated with all-cause mortality in anticoagulated patients with atrial fibrillation.

artículo científico publicado en 2015

β-Trace protein and prognosis in patients with atrial fibrillation receiving anticoagulation treatment

artículo científico publicado en 2013

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda